Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01135355 · ClinicalTrials.gov registry record
Cytokine Assay for Early Identification of Pediatric Stem Cell Transplant Recipients
A clinical trial, sponsored by Stanford University.
- Terminated
- Registry status
- 26
- Enrollment target
NCT01135355: Clinical Trial study, sponsored by Stanford University.
NCT01135355 is a clinical trial that was terminated before completion, run by Stanford University. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01135355 was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- 26 participants
- Enrollment target
Study Summary
The aim of our study is to determine whether a clinically relevant laboratory measurement (of seven specific immunologic biochemicals in the blood) can identify which bone marrow transplant recipients are likely to progress to respiratory failure. Our ultimate goal is to devise a comprehensive and inclusive laboratory test that is effective at determining who is likely to go on to respiratory failure, in order to facilitate early medical intervention.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2008-07 |
| Est. Completion | 2011-01 |
Why NCT01135355 stopped before completion
NCT01135355 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 26 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01135355 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01135355 about?
NCT01135355 is a clinical study titled "Cytokine Assay for Early Identification of Pediatric Stem Cell Transplant Recipients". The aim of our study is to determine whether a clinically relevant laboratory measurement (of seven specific immunologic biochemicals in the blood) can identify which bone marrow transplant recipients are likely to progress to respiratory failure. Our ultimate goal is to devise a comprehensive and i...
What is the current status of trial NCT01135355?
This trial is currently terminated. The enrollment target is 26 participants. The study started on 2008-07. Estimated completion is 2011-01.
Who is sponsoring clinical trial NCT01135355?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia